… Systemic corticosteroids are commonly used in treating severe COVID-19. However, the
role of inhaled corticosteroids in the treatment of patients with mild to moderate disease is less …

… We also discuss the role of these therapies in the prevention and treatment of COVID-19-…
RECOVERY randomly assigned 6,425 hospitalized adult patients with COVID-19 to receive …

… As there is no evidence for a specific superior empirical treatment strategy in patients with
COVID-19 and bacterial pneumonia, we recommend to follow local and/or national guidelines …

… ChiCTR2000030041 A single-arm, single-center clinical trial for azvudine tablets in the
treatment of adult novel coronavirus pneumonia (COVID-19) Azvudine tablets (40 patients) The …

… adults with COVID-19. This guideline does not address in detail the management of COVID-19
… We recommend further trials of high versus low dose corticosteroid treatment in COVID-19…

… On December 23, 2021, the FDA issued an Emergency Use Authorization for molnupiravir
for treatment of adults with mild to moderate COVID-19 who are at high risk for progression …

… by viral infections such as COVID-19. We present results from a nonrandomized proof-of-concept
study of complement C5 inhibitor eculizumab for treatment of severe COVID-19. …

… a population of nearly 100 000 adult inhabitants, a treatment protocol with colchicine was
proposed to consecutive patients admitted for COVID-19 as adjunct treatment to the SoC,14 (…

… It is noteworthy that adults with coronavirus disease 2019 (COVID-19) often present with a
profound decrease in both CD4 + and CD8 + T-cell subsets at the early stage of this disease. …

… adults have also succumbed to COVID-19. Once hospitalized, for some patients, death can
occur within a few days, many with adult … The ideal treatment for COVID-19–induced CSS is …